86. 肺動脈性肺高血圧症 Pulmonary arterial hypertension Clinical trials / Disease details


臨床試験数 : 1,205 薬物数 : 684 - (DrugBank : 124) / 標的遺伝子数 : 100 - 標的パスウェイ数 : 193

  
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2005-004863-41-DE
(EUCTR)
04/10/200625/07/2006Clinical investigation into efficacy, hemodynamics and tolerability of simvastatin vs placebo in patients with pulmonary arterial hypertension(Shorttitle: SIPHT)Double-blind, randomized, prospective Phase III-b study for 6 months with adjusting doses of simvastatin (40/80 mg daily) or placebo followed by an open-label period with a final dose of simvastatin 80 mg daily for another 6 months - SIPHTClinical investigation into efficacy, hemodynamics and tolerability of simvastatin vs placebo in patients with pulmonary arterial hypertension(Shorttitle: SIPHT)Double-blind, randomized, prospective Phase III-b study for 6 months with adjusting doses of simvastatin (40/80 mg daily) or placebo followed by an open-label period with a final dose of simvastatin 80 mg daily for another 6 months - SIPHT Modified NYHA class II or III patients with Pulmonary Hypertension (PH), ICD: 416.9
MedDRA version: 8.1;Level: LLT;Classification code 10020787;Term: Hypertension pulmonary
Trade Name: simvastatin 40 mg tablets
Product Name: simvastatin
Product Name: simvastatin 40 mg
Product Code: simvastatin 40 mg
INN or Proposed INN: simvastatin
Dept. of Internal Medicine II, University Hospital GiessenNULLNot RecruitingFemale: yes
Male: yes
40Phase 3Germany
2NCT00384865
(ClinicalTrials.gov)
September 200630/9/2006A Study of Aspirin and Simvastatin in Pulmonary Arterial HypertensionA Clinical Trial of Aspirin and Simvastatin in Pulmonary Arterial HypertensionHypertension, PulmonaryDrug: Simvastatin;Drug: Aspirin;Drug: PlaceboUniversity of PennsylvaniaNational Heart, Lung, and Blood Institute (NHLBI)Terminated18 YearsN/AAll64Phase 2United States